Shareholders Agreements in the Biotechnology Industry
54 Contracts & Agreements
- ADURO BIOTECH, INC. (1 contract)
- Allogene Therapeutics, Inc. (1)
- Amgen Inc. (2)
- Anchiano Therapeutics Ltd. (2)
- Anika Therapeutics (1)
- AQUINOX PHARMACEUTICALS, INC (4)
- Biostage, Inc. (3)
- BIOTIME INC (2)
- Bison Capital Acquisition Corp. (1)
- CM Life Sciences III Inc. (1)
- CTI BIOPHARMA CORP (4)
- DYADIC INTERNATIONAL INC (1)
- Eagle Pharmaceuticals, Inc. (2)
- Exelixis (1)
- FIBROGEN INC (1)
- Fortress Biotech, Inc. (1)
- GENEREX BIOTECHNOLOGY CORP (1)
- HOOKIPA Pharma Inc. (1)
- Immune Therapeutics, Inc. (1)
- INSMED Inc (1)
- Intec Pharma Ltd. (1)
- Isoray, Inc. (1)
- KalVista Pharmaceuticals, Inc. (2)
- LEAP THERAPEUTICS, INC. (2)
- LianBio (1)
- MeiraGTx Holdings plc (1)
- OncBioMune Pharmaceuticals, Inc (2)
- Orgenesis Inc. (1)
- Petra Acquisition Inc. (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- RECURSION PHARMACEUTICALS, INC. (1)
- Sarepta Therapeutics, Inc. (1)
- SPHERIX INC (1)
- Spinning Eagle Acquisition Corp. (1)
- Vericel Corp (2)
- XOMA Corp (2)
- YIELD10 BIOSCIENCE, INC. (1)
- Registration Agreement dated May 25, 2023 by and among the Registrant, Recursion Canada Inc., and certain shareholders of Cyclica Inc (RECURSION PHARMACEUTICALS, INC., Filed With SEC on June 9, 2023)
- Form of Shareholder Lock-up Agreement (Eagle Pharmaceuticals, Inc., Filed With SEC on March 28, 2022)
- Form of Shareholder Undertaking (Eagle Pharmaceuticals, Inc., Filed With SEC on March 28, 2022)
- SanReno Shareholders Agreement between the Registrant and SanReno Therapeutics Holdings Limited and SanReno Therapeutics (Hong Kong) Limited, a wholly owned subsidiary of SanReno... (ADURO BIOTECH, INC., Filed With SEC on March 17, 2022)
- Second Amended and Restated Shareholders Agreement dated October 28, 2020, by and among LianBio and the investors party thereto (LianBio, Filed With SEC on October 1, 2021)
- Form of Shareholder Lock-Up Agreement (CM Life Sciences III Inc., Filed With SEC on August 6, 2021)
- Sponsor Support Agreement, dated as of May 11, 2021, by and among Eagle Equity Partners III, LLC, Ginkgo Bioworks, Inc., Soaring Eagle Acquisition Corp. and certain of its... (Spinning Eagle Acquisition Corp., Filed With SEC on May 11, 2021)
- Form of Letter Agreement from each of the Registrants initial shareholders, officers and directors (Petra Acquisition Inc., Filed With SEC on March 31, 2021)
- Form of Intec Shareholder Support Agreement (Intec Pharma Ltd., Filed With SEC on March 15, 2021)
- Shareholders' Agreement, dated December 14, 2020, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited (Allogene Therapeutics, Inc., Filed With SEC on February 25, 2021)
- Amendment 2 to Shareholder Rights Agreement, dated as of February 11, 2021 (Vericel Corp, Filed With SEC on February 24, 2021)
- Form of Chemomab Shareholder Support Agreement, dated December 14, 2020, by and between Anchiano Therapeutics Ltd. and each of the parties named in each agreement thereof (Anchiano Therapeutics Ltd., Filed With SEC on December 15, 2020)
- Form of Company Shareholder Support Agreement, dated December 14, 2020, by and between Chemomab Ltd. and each of the parties named in each agreement thereof (Anchiano Therapeutics Ltd., Filed With SEC on December 15, 2020)
- Form of Shareholders Lock-Up Agreement between the Company and Shareholders other than Long Hill Capital V, LLC (Orgenesis Inc., Filed With SEC on October 1, 2020)
- Shareholder Agreement (MeiraGTx Holdings plc, Filed With SEC on March 11, 2020)
- Letter to Shareholders (Immune Therapeutics, Inc., Filed With SEC on May 15, 2019)
- Shareholders Agreement among Dyadic International (USA), Inc., JCL Biologics Pty Ltd and Novovet Pty Ltd, dated April 26, 2019 (DYADIC INTERNATIONAL INC, Filed With SEC on May 2, 2019)
- Shareholders Agreement among HOOKIPA Pharma Inc. and certain of its shareholders, dated February 15, 2019 (HOOKIPA Pharma Inc., Filed With SEC on April 23, 2019)
- Shareholders Agreement among OncBioMune Pharmaceuticals, Inc., Jonathan F. Head, Ph.D., Andrew A. Kucharchuk, Manuel Cosme Odabachian and Carlos Fernando Alaman Volnie dated March... (OncBioMune Pharmaceuticals, Inc, Filed With SEC on February 21, 2019)
- AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (GENEREX BIOTECHNOLOGY CORP, Filed With SEC on January 11, 2019)
- Shareholder Agreement, dated August 30, 2018 between BioTime, Inc. and Juvenescence Limited (BIOTIME INC, Filed With SEC on August 31, 2018)
- Shareholders Agreement by and among FibroGen International (Cayman) Limited and certain of its shareholders, dated as of September 8, 2017 (FIBROGEN INC, Filed With SEC on November 8, 2017)
- Fourth Amendment to Shareholder Rights Agreement, dated as of 22, 2017, between the Company and Computershare Trust Company, N.A., as Rights Agent (CTI BIOPHARMA CORP, Filed With SEC on September 26, 2017)
- AMENDMENT NO. 2 TO SHAREHOLDER RIGHTS AGREEMENT (Biostage, Inc., Filed With SEC on August 17, 2017)
- Form of Shareholders Agreement, dated as of June 30, 2017 (SPHERIX INC, Filed With SEC on July 3, 2017)
- Letter Agreement, dated June 19, 2017, among the Company, EarlyBirdCapital, Inc. and each shareholder, director and officer of the Company (Bison Capital Acquisition Corp., Filed With SEC on June 26, 2017)
- ROYALTY AGREEMENT BETWEEN LEAP THERAPEUTICS, INC. AND LEAP SHAREHOLDER ROYALTY VEHICLE, LLC EFFECTIVE AS OF JANUARY 23, 2017 (LEAP THERAPEUTICS, INC., Filed With SEC on January 26, 2017)
- SHAREPURCHASE AGREEMENT BY AND AMONG CARBYLAN THERAPEUTICS, INC., THE SHAREHOLDERS OF KALVISTA PHARMACEUTICALS LTD., KALVISTA PHARMACEUTICALS LTD. AND THE SELLERREPRESENTATIVE... (KalVista Pharmaceuticals, Inc., Filed With SEC on November 23, 2016)
- ROYALTY AGREEMENT BETWEEN LEAP THERAPEUTICS, INC. AND [LEAP SHAREHOLDER ROYALTY VEHICLE, LLC] EFFECTIVE AS OF [], 2016 (LEAP THERAPEUTICS, INC., Filed With SEC on September 26, 2016)
- SHAREHOLDERSaGREEMENT byand between OncbiomuneMéxico, s.A. de c.v. asthe Company, and VitelLaboratorios, S.A. de C.V. and OncBioMune Pharmaceuticals Inc. as Shareholders Datedas... (OncBioMune Pharmaceuticals, Inc, Filed With SEC on August 26, 2016)
- SHAREPURCHASE AGREEMENT BY AND AMONG CARBYLAN THERAPEUTICS, INC., THE SHAREHOLDERS OF KALVISTA PHARMACEUTICALS LTD., KALVISTA PHARMACEUTICALS LTD. AND THE SELLERREPRESENTATIVE... (KalVista Pharmaceuticals, Inc., Filed With SEC on June 15, 2016)
- THIRD AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (CTI BIOPHARMA CORP, Filed With SEC on December 1, 2015)
- AMENDMENT NO. 1 TO SHAREHOLDER RIGHTS AGREEMENT (Biostage, Inc., Filed With SEC on February 12, 2015)
- Consolidated Shareholders Agreement 2014 Pieris AG, Freising, Germany dated October 10, 2014 by and among (PIERIS PHARMACEUTICALS, INC., Filed With SEC on December 18, 2014)
- AMENDMENT NO. 14 TO THE SHAREHOLDERS AGREEMENT OF KIRIN-AMGEN, INC. (Amgen Inc., Filed With SEC on April 30, 2014)
- SHAREHOLDERS’ AGREEMENT (Fortress Biotech, Inc., Filed With SEC on February 26, 2014)
- AMENDMENT NO. 3 TO SHAREHOLDERS AGREEMENT (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on January 28, 2014)
- AMENDMENT NO. 2 TO SHAREHOLDERS AGREEMENT (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on January 28, 2014)
- AMENDMENT TO SHAREHOLDERS AGREEMENT (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on January 28, 2014)
- AMENDED & RESTATED SHAREHOLDERS AGREEMENT (AQUINOX PHARMACEUTICALS, INC, Filed With SEC on January 28, 2014)
